Precision Oncology Diagnostics Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2035

Precision Oncology Diagnostics Market: By Test Type (Comprehensive Genomic Profiling, Liquid Biopsy (ctDNA), Companion Diagnostics, Minimal Residual Disease Monitoring, Immunohistochemistry & Protein); Technology (Next-Generation Sequencing, PCR, Digital PCR, Mass Spectrometry, Multi-Omic Platforms); Sample Type (Tissue, Blood/Plasma, Other Body Fluids); Cancer Type (Lung, Breast, Colorectal, Haematologic, Prostate, Pan-Cancer); End User (Hospitals & Cancer Centres, Reference Laboratories, Biopharma (Trials & CDx), Community Oncology)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035

The precision oncology diagnostics market is estimated at USD 12.5 billion in 2025 and is projected to reach USD 39 billion by 2035, growing at a CAGR of 12.1% over the forecast period 2026–2035. Read More

We Are Trusted By These Great Companies!

• Last Updated: 28-Sep-2026  |  Format:  |  Report ID: AA09262002